![PPT - A Neurologist's View of Second Generation AEDs: Characteristics, Guidelines and Patient Selection PowerPoint Presentation - ID:169182 PPT - A Neurologist's View of Second Generation AEDs: Characteristics, Guidelines and Patient Selection PowerPoint Presentation - ID:169182](https://image.slideserve.com/169182/levetiracetam-keppra-cont-l.jpg)
PPT - A Neurologist's View of Second Generation AEDs: Characteristics, Guidelines and Patient Selection PowerPoint Presentation - ID:169182
![Table 1 from Improvements in a program to convert i.v. to oral medications at an academic medical center. | Semantic Scholar Table 1 from Improvements in a program to convert i.v. to oral medications at an academic medical center. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/21dccde0eeecc7d99c10657320410586ebba2875/4-Table1-1.png)
Table 1 from Improvements in a program to convert i.v. to oral medications at an academic medical center. | Semantic Scholar
![Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial - The Lancet Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/65fd8266-a008-4e55-8d1c-defa62748c09/gr1.gif)
Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial - The Lancet
![PDF) Evaluation of levetiracetam and valproic acid as monotherapy on quality of life in patients of generalized tonic clonic epilepsy PDF) Evaluation of levetiracetam and valproic acid as monotherapy on quality of life in patients of generalized tonic clonic epilepsy](https://www.researchgate.net/profile/Juhi-Kalra/publication/323973732/figure/tbl1/AS:668945216438275@1536500376284/Basic-demographic-profile-of-the-patients-included-in-the-study_Q320.jpg)
PDF) Evaluation of levetiracetam and valproic acid as monotherapy on quality of life in patients of generalized tonic clonic epilepsy
![Frontiers | Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options | Psychiatry Frontiers | Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options | Psychiatry](https://www.frontiersin.org/files/Articles/595584/fpsyt-11-595584-HTML-r1/image_m/fpsyt-11-595584-t001.jpg)